randall morris

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Chemicals & Drugs

Physiology

Living Beings

Procedures

Disorders

Bronchiolitis Obliterans

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Skvara Hans; Dawid Markus; Kleyn Elise; Wolff Barbara; Meingassner Josef G; Knight Hilary; Dumortier Thomas; Kopp Tamara; Fallahi Nasanin; Stary Georg; Burkhart Christoph; Grenet Olivier; Wagner Juergen; Hijazi Youssef; Morris Randall E; McGeown Claire; Rordorf Christiane; Griffiths Christopher E M; Stingl Georg; Jung Thomas
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
Morris Randall E
Discovery and development of immunosuppressants for transplantation: what are the lessons for specialty medicines?
Zahorsky-Reeves Joanne L; Kearns-Jonker Mary K; Lam Tuan T; Jackson Jeremy R; Morris Randall E; Starnes Vaughn A; Cramer Donald V
The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of randall morris (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2008: Skvara Hans; Dawid Markus; Kleyn Elise; Wolff Barbara; Meingassner Josef G; Knight Hilary; Dumortier Thomas; Kopp Tamara; Fallahi Nasanin; Stary Georg; Burkhart Christoph; Grenet Olivier; Wagner Juergen; Hijazi Youssef; Morris Randall E; McGeown Claire; Rordorf Christiane; Griffiths Christopher E M; Stingl Georg; Jung Thomas
The PKC inhibitor AEB071 may be a therapeutic option for psoriasis.
The Journal of clinical investigation 2008;118(9):3151-9.
2008: Morris Randall E
Discovery and development of immunosuppressants for transplantation: what are the lessons for specialty medicines?
Current opinion in investigational drugs (London, England : 2000) 2008;9(5):451-4.
2007: Zahorsky-Reeves Joanne L; Kearns-Jonker Mary K; Lam Tuan T; Jackson Jeremy R; Morris Randall E; Starnes Vaughn A; Cramer Donald V
The xenoantibody response and immunoglobulin gene expression profile of cynomolgus monkeys transplanted with hDAF-transgenic porcine hearts.
Xenotransplantation 2007;14(2):135-44.
2005: Stalder Mario; Bîrsan Tudor; Hausen Bernard; Borie Dominic C; Morris Randall E
Immunosuppressive effects of surgery assessed by flow cytometry in nonhuman primates after nephrectomy.
Transplant international : official journal of the European Society for Organ Transplantation 2005;18(10):1158-65.
2005: Chan M C Y; Stalder M; Lam T T; Tye T; Borie D C; Morris R E
Use of echocardiography to assess function of hDAF-transgenic pig cardiac xenografts.
Transplantation proceedings 2005;37(4):1923-5.
2005: Bîrsan Tudor; Dambrin Camille; Freitag Derrick G; Yatscoff Randall W; Morris Randall E
The novel calcineurin inhibitor ISA247: a more potent immunosuppressant than cyclosporine in vitro.
Transplant international : official journal of the European Society for Organ Transplantation 2005;17(12):767-71.
2005: Borie Dominic C; Changelian Paul S; Larson Michael J; Si Ming-Sing; Paniagua Ricardo; Higgins John P; Holm Bari; Campbell Andrew; Lau Macy; Zhang Sally; Flores Mona G; Rousvoal Geraldine; Hawkins Jennifer; Ball Douglas A; Kudlacz Elizabeth M; Brissette William H; Elliott Eileen A; Reitz Bruce A; Morris Randall E
Immunosuppression by the JAK3 inhibitor CP-690,550 delays rejection and significantly prolongs kidney allograft survival in nonhuman primates.
Transplantation 2005;79(7):791-801.
2005: Stalder Mario; Tye Terry; Lam Tuan T; Chan Michael C Y; Berry Gerald J; Borie Dominic C; Morris Randall E
Improved assessment of graft function by echocardiography in cynomolgus monkey recipients of hDAF-transgenic pig cardiac xenografts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2005;24(2):215-21.
2005: Lam Tuan T; Hausen Bernard; Hook Laurie; Lau Macy; Higgins John; Christians Uwe; Jacobsen Wolfgang; Baluom Muhammad; Duthaler Rudolf; Katopodis Andreas; Chavez Gilda; Cozzi Emanuele; Harrison Richard; Schuurman Henk-Jan; Borie Dominique; Morris Randall E
The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.
Xenotransplantation 2005;12(1):20-9.
2004: Lam Tuan T; Paniagua Ricardo; Shivaram Giridhar; Schuurman Henk-Jan; Borie Dominique C; Morris Randall E
Anti-non-Gal porcine endothelial cell antibodies in acute humoral xenograft rejection of hDAF-transgenic porcine hearts in cynomolgus monkeys.
Xenotransplantation 2004;11(6):531-5.
2004: Lam Tuan T; Hausen Bernard; Boeke-Purkis Katrin; Paniagua Ricardo; Lau Macy; Hook Laurie; Berry Gerry; Higgins John; Duthaler Rudolf O; Katopodis Andreas G; Robbins Robert; Reitz Bruce; Borie Dominique; Schuurman Henk-Jan; Morris Randall E
Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.
Xenotransplantation 2004;11(6):517-24.
2004: Gregory Clare R; Kyles Andrew E; Bernsteen Lynda; Wagner Gerhardt S; Tarantal Alice F; Christe Kari L; Brignolo Lori; Spinner Abigail; Griffey Stephen M; Paniagua Ricardo T; Hubble Richard W; Borie Dominic C; Morris Randall E
Compared with cyclosporine, ISATX247 significantly prolongs renal-allograft survival in a nonhuman primate model.
Transplantation 2004;78(5):681-5.
2004: Lam Tuan T; Boeke-Purkis Katrin; Lau Macy; Paniagua Ricardo; Schuurman Henk-Jan; Morris Randall E
Anti-pig antibody levels in non-human primates of various origin.
Xenotransplantation 2004;11(4):332-9.
2004: Flores Mona G; Zhang Sally; Ha Ann; Holm Bari; Reitz Bruce A; Morris Randall E; Borie Dominic C
In vitro evaluation of the effects of candidate immunosuppressive drugs: flow cytometry and quantitative real-time PCR as two independent and correlated read-outs.
Journal of immunological methods 2004;289(1-2):123-35.
2004: Murata Seiichiro; Sundell Cynthia L; Lijkwan Maarten A; Balsam Leora B; Hammainen Pekka; Coleman Caroline; York Chris; Luchoomun Jayraz; Suen Ki-Ling; Howard Randy; Somers Patricia K; Morris Randall E; Robbins Robert C
Effects of AGI-1096, a novel antioxidant compound with anti-inflammatory and antiproliferative properties, on rodent allograft arteriosclerosis.
Transplantation 2004;77(10):1494-500.
2004: Morris R E
The future of immunosuppression: a personal view.
Transplantation proceedings 2004;36(2 Suppl):577S-579S.
2004: Klupp Jochen; van Gelder Teun; Dambrin Camille; Regieli Jakub J; Boeke Katrin; Billingham Margaret E; Morris Randall E
Sustained suppression of peripheral blood immune functions by treatment with mycophenolate mofetil correlates with reduced severity of cardiac allograft rejection.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2004;23(3):334-51.
2004: Briffa Norman P; Shorthouse Randi; Chan Jason; Silva Helio; Billingham Margaret; Brazelton Timothy; Morris Randall E
Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy.
Xenotransplantation 2004;11(2):149-59.
2004: Bîrsan Tudor; Dambrin Camille; Marsh Kennan C; Jacobsen Wolfgang; Djuric Stevan W; Mollison Karl W; Christians Uwe; Carter George W; Morris Randall E
Preliminary in vivo pharmacokinetic and pharmacodynamic evaluation of a novel calcineurin-independent inhibitor of NFAT.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(3):145-50.
2003: Stalder Mario; Bîrsan Tudor; Hubble Richard W; Paniagua Ricardo T; Morris Randall E
In vivo evaluation of the novel calcineurin inhibitor ISATX247 in non-human primates.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2003;22(12):1343-52.
2003: Borie Dominic C; Si Ming-Sing; Morris Randall E; Reitz Bruce A; Changelian Paul S
JAK3 inhibition as a new concept for immune suppression.
Current opinion in investigational drugs (London, England : 2000) 2003;4(11):1297-303.
2003: Changelian Paul S; Flanagan Mark E; Ball Douglas J; Kent Craig R; Magnuson Kelly S; Martin William H; Rizzuti Bonnie J; Sawyer Perry S; Perry Bret D; Brissette William H; McCurdy Sandra P; Kudlacz Elizabeth M; Conklyn Maryrose J; Elliott Eileen A; Koslov Erika R; Fisher Michael B; Strelevitz Timothy J; Yoon Kwansik; Whipple David A; Sun Jianmin; Munchhof Michael J; Doty John L; Casavant Jeffrey M; Blumenkopf Todd A; Hines Michael; Brown Matthew F; Lillie Brett M; Subramanyam Chakrapani; Shang-Poa Chang; Milici Anthony J; Beckius Gretchen E; Moyer James D; Su Chunyan; Woodworth Thasia G; Gaweco Anderson S; Beals Chan R; Littman Bruce H; Fisher Douglas A; Smith James F; Zagouras Panayiotis; Magna Holly A; Saltarelli Mary J; Johnson Kimberly S; Nelms Linda F; Des Etages Shelley G; Hayes Lisa S; Kawabata Thomas T; Finco-Kent Deborah; Baker Deanna L; Larson Michael; Si Ming-Sing; Paniagua Ricardo; Higgins John; Holm Bari; Reitz Bruce; Zhou Yong-Jie; Morris Randall E; O'Shea John J; Borie Dominic C
Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor.
Science (New York, N.Y.) 2003;302(5646):875-8.
2003: Singer Lianne G; Brazelton Timothy R; Doyle Ramona L; Morris Randall E; Theodore James;
Weight gain after lung transplantation.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2003;22(8):894-902.
2003: Klupp Jochen; Dambrin Camille; Hibi Kiyoshi; Luna Jorge; Suzuki Takeshi; Hausen Bernard; Birsan Tudor; Van Gelder Teun; Fitzgerald Peter J; Berry Gerald; Morris Randall E
Treatment by mycophenolate mofetil of advanced graft vascular disease in non-human primate recipients of orthotopic aortic allografts.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2003;3(7):817-29.
2003: Bîrsan Tudor; Hausen Bernard; Higgins John P; Hubble Richard W; Klupp Jochen; Stalder Mario; Celniker Abbie; Friedrich Stuart; O'Hara Richard M; Morris Randall E
Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys.
Transplantation 2003;75(12):2106-13.
2003: Kyles Andrew E; Gregory Clare R; Griffey Stephen M; Bernsteen Lynda; Morris Randall E
Modified noble plication for the prevention of intestinal intussusception after renal transplantation in dogs.
Journal of investigative surgery : the official journal of the Academy of Surgical Research 2003;16(3):161-6.
2003: Bîrsan Tudor; Dambrin Camille; Klupp Jochen; Stalder Mario; Larson Michael J; Fitzsimmons William E; Morris Randall E
In vivo pharmacokinetic and pharmacodynamic evaluation of the malononitrilamide FK778 in non-human primates.
Transplant international : official journal of the European Society for Organ Transplantation 2003;16(5):354-60.
2003: Bîrsan Tudor; Dambrin Camille; Klupp Jochen; Stalder Mario; Fitzsimmons William E; Morris Randall E
Effects of the malononitrilamide FK778 on immune functions in vitro in whole blood from non-human primates and healthy human volunteers.
Transplant immunology 2003;11(2):163-7.
2003: Kyles Andrew E; Gregory Clare R; Griffey Stephen M; Bernsteen Lynda; Pierce Jon; Lilja Herman S; Morris Randall E
Immunosuppression with a combination of the leflunomide analog, FK778, and microemulsified cyclosporine for renal transplantation in mongrel dogs.
Transplantation 2003;75(8):1128-33.
2003: Lam Tuan T; Borie Dominique; Masek Marilyn; Berry Gerald; Larson Michael; Morris Randall E
Graft thrombosis in hDA-transgenic pig hearts transplanted into rhesus monkeys.
Xenotransplantation 2003;10(2):185-6.
2003: Stalder Mario; Bîrsan Tudor; Holm Bari; Haririfar Mojgan; Scandling John; Morris Randall E
Quantification of immunosuppression by flow cytometry in stable renal transplant recipients.
Therapeutic drug monitoring 2003;25(1):22-7.
2002: Barten Markus J; van Gelder Teun; Gummert Jan F; Boeke Katrin; Shorthouse Randi; Billingham Margaret E; Morris Randall E
Pharmacodynamics of mycophenolate mofetil after heart transplantation: new mechanisms of action and correlations with histologic severity of graft rejection.
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2002;2(8):719-32.
2002: Lam T T; Hausen B; Squiers E; Cozzi E; Morris R E
Cyclophosphamide-induced postoperative anemia in cynomolgus monkey recipients of hDAF-transgenic pig organ xenografts.
Transplantation proceedings 2002;34(5):1451-2.
2002: Kyles Andrew E; Gregory Clare R; Griffey Stephen M; Jackson Joshua; Bernsteen Lynda; Morris Randall E
An evaluation of combined immunosuppression with MNA 715 and microemulsified cyclosporine on renal allograft rejection in mismatched mongrel dogs.
Veterinary surgery : VS : the official journal of the American College of Veterinary Surgeons 2002;31(4):358-66.
2002: Barten Markus J; van Gelder Teun; Gummert Jan F; Shorthouse Randi; Morris Randall E
Novel assays of multiple lymphocyte functions in whole blood measure: new mechanisms of action of mycophenolate mofetil in vivo.
Transplant immunology 2002;10(1):1-14.
2002: Kyles Andrew E; Gregory Clare R; Griffey Stephen M; Galvez Jose; Ramsamooj Rajen; Morris Randall E
Evaluation of the clinical and histologic features of renal allograft rejection in cats.
Veterinary surgery : VS : the official journal of the American College of Veterinary Surgeons 2002;31(1):49-56.
2002: Dosanjh A; Ikonen T; Wan B; Morris R E
Pirfenidone: A novel anti-fibrotic agent and progressive chronic allograft rejection.
Pulmonary pharmacology & therapeutics 2002;15(5):433-7.
2001: Dosanjh A; Wan B; Ikonen T; Boeke K; Morris R E
Airway goblet cells and respiratory epithelial injury in an animal model of obliterative airways disease (OAD).
American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 2001;1(4):321-4.
2001: Vriens P W; Pollard J D; Hoyt G; Morris R E; Scheringa M; Bouwman E; Robbins R C
Hamster cardiac xenografts are protected against antibody mediated damage, early after transplantation to Lewis rats.
Xenotransplantation 2001;8(4):239-46.
2001: Hausen B; Klupp J; Christians U; Higgins J P; Baumgartner R E; Hook L E; Friedrich S; Celnicker A; Morris R E
Coadministration of either cyclosporine or steroids with humanized monoclonal antibodies against CD80 and CD86 successfully prolong allograft survival after life supporting renal transplantation in cynomolgus monkeys.
Transplantation 2001;72(6):1128-37.
2001: Hausen B; Boeke K; Berry G J; Morris R E
Viral serine proteinase inhibitor (SERP-1) effectively decreases the incidence of graft vasculopathy in heterotopic heart allografts.
Transplantation 2001;72(3):364-8.
2001: Barten M J; Gummert J F; van Gelder T; Shorthouse R; Morris R E
Flow cytometric quantitation of calcium-dependent and -independent mitogen-stimulation of T cell functions in whole blood: inhibition by immunosuppressive drugs in vitro.
Journal of immunological methods 2001;253(1-2):95-112.
2001: Morris R E
Vascular and cellular mechanisms of chronic renal allograft dysfunction.
Transplantation 2001;71(11 Suppl):SS37-41.
2001: Morikawa M; Brazelton T R; Berry G J; Morris R E
Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody.
Transplantation 2001;71(11):1616-21.
2001: Barten M J; van Gelder T; Gummert J F; Shorthouse R; Boeke K; Billingham M E; Morris R E
New mechanisms of action of mycophenolate mofetil in transplant recipients by assessment of its pharmacodynamics.
Transplantation proceedings 2001;33(3):2254-5.
2001: Klupp J; Dambrin C; Regieli J; van Gelder T; Shorthouse R; Morris R E
New approach in drug development: whole blood pharmacodynamic assays reflect biological activities of tacrolimus.
Transplantation proceedings 2001;33(3):2172.
2001: Klupp J; van Gelder T; Dambrin C; Regieli J; Boeke K; Billingham M E; Morris R E
Mycophenolate mofetil pharmacodynamics and pharmacokinetics correlate with rejection score in a BN-to-LEW heterotopic heart transplant model.
Transplantation proceedings 2001;33(3):2170-1.
2001: Barten M J; Gummert J F; van Gelder T; Shorthouse R; Morris R E
Assessment of mechanisms of action of immunosuppressive drugs using novel whole blood assays.
Transplantation proceedings 2001;33(3):2119-20.
2001: van Gelder T; Klupp J; Barten M J; Christians U; Morris R E
Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
Therapeutic drug monitoring 2001;23(2):119-28.
2001: Doyle R L; Hertz M I; Dunitz J M; Loyd J E; Stecenko A A; Wong R L; Chappell K A; Brazelton T; Kovarik J M; Appeldingemanse S; Dou L; Smith H T; Tudor D; Morris R E
RAD in stable lung and heart/lung transplant recipients: safety, tolerability, pharmacokinetics, and impact of cystic fibrosis.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2001;20(3):330-9.
2001: Jacobsen W; Serkova N; Hausen B; Morris R E; Benet L Z; Christians U
Comparison of the in vitro metabolism of the macrolide immunosuppressants sirolimus and RAD.
Transplantation proceedings 2001;33(1-2):514-5.
2001: Kyles A E; Gregory C R; Griffey S M; Bernsteen L; Jackson J; Morris R E
Leflunomide analog, MNA-715, plus cyclosporine reduces renal allograft rejection in mismatched dogs.
Transplantation proceedings 2001;33(1-2):368-9.
2001: Dosanjh A; Morris R E; Wan B
Bronchial epithelial cell-derived cytokine IL-10 and lung fibroblast proliferation.
Transplantation proceedings 2001;33(1-2):352-4.
2000: Gummert J F; Barten M J; van Gelder T; Billingham M E; Morris R E
Pharmacodynamics of mycophenolic acid in heart allograft recipients: correlation of lymphocyte proliferation and activation with pharmacokinetics and graft histology.
Transplantation 2000;70(7):1038-49.
2000: Dambrin C; Klupp J; Morris R E
Pharmacodynamics of immunosuppressive drugs.
Current opinion in immunology 2000;12(5):557-62.
2000: Ikonen T S; Gummert J F; Hayase M; Honda Y; Hausen B; Christians U; Berry G J; Yock P G; Morris R E
Sirolimus (rapamycin) halts and reverses progression of allograft vascular disease in non-human primates.
Transplantation 2000;70(6):969-75.
2000: Ikonen T S; Brazelton T R; Berry G J; Shorthouse R S; Morris R E
Epithelial re-growth is associated with inhibition of obliterative airway disease in orthotopic tracheal allografts in non-immunosuppressed rats.
Transplantation 2000;70(6):857-63.
2000: Ikonen T S; Briffa N; Gummert J F; Honda Y; Hayase M; Hausen B; Billingham M E; Yock P G; Robbins R C; Morris R E
Multidimensional assessment of graft vascular disease (GVD) in aortic grafts by serial intravascular ultrasound in rhesus monkeys.
Transplantation 2000;70(3):420-9.
2000: Serkova N; Hausen B; Berry G J; Jacobsen W; Benet L Z; Morris R E; Christians U
Tissue distribution and clinical monitoring of the novel macrolide immunosuppressant SDZ-RAD and its metabolites in monkey lung transplant recipients: interaction with cyclosporine.
The Journal of pharmacology and experimental therapeutics 2000;294(1):323-32.
2000: Adams B F; Berry G J; Huang X; Shorthouse R; Brazelton T; Morris R E
Immunosuppressive therapies for the prevention and treatment of obliterative airway disease in heterotopic rat trachea allografts.
Transplantation 2000;69(11):2260-6.
2000: Poston R S; Robbins R C; Chan B; Simms P; Presta L; Jardieu P; Morris R E
Effects of humanized monoclonal antibody to rhesus CD11a in rhesus monkey cardiac allograft recipients.
Transplantation 2000;69(10):2005-13.
2000: Romanska H M; Ikonen T S; Bishop A E; Morris R E; Polak J M
Up-regulation of inducible nitric oxide synthase in fibroblasts parallels the onset and progression of fibrosis in an experimental model of post-transplant obliterative airway disease.
The Journal of pathology 2000;191(1):71-7.
2000: Hausen B; Boeke K; Berry G J; Christians U; Schüler W; Morris R E
Successful treatment of acute, ongoing rat lung allograft rejection with the novel immunosuppressant SDZ-RAD.
The Annals of thoracic surgery 2000;69(3):904-9.
2000: Adams B F; Brazelton T; Berry G J; Morris R E
The role of respiratory epithelium in a rat model of obliterative airway disease.
Transplantation 2000;69(4):661-4.
2000: Hausen B; Gummert J; Berry G J; Christians U; Serkova N; Ikonen T; Hook L; Legay F; Schuler W; Schreier M H; Morris R E
Prevention of acute allograft rejection in nonhuman primate lung transplant recipients: induction with chimeric anti-interleukin-2 receptor monoclonal antibody improves the tolerability and potentiates the immunosuppressive activity of a regimen using low doses of both microemulsion cyclosporine and 40-O-(2-hydroxyethyl)-rapamycin.
Transplantation 2000;69(4):488-96.
2000: Hausen B; Ikonen T; Briffa N; Berry G J; Christians U; Robbins R C; Hook L; Serkova N; Benet L Z; Schuler W; Morris R E
Combined immunosuppression with cyclosporine (neoral) and SDZ RAD in non-human primate lung transplantation: systematic pharmacokinetic-based trials to improve efficacy and tolerability.
Transplantation 2000;69(1):76-86.
2000: Ikonen T S; Gummert J F; Serkova N; Hayase M; Honda Y; Kobayase Y; Hausen B; Yock P G; Christians U; Morris R E
Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening.
Transplant international : official journal of the European Society for Organ Transplantation 2000;13 Suppl 1():S314-20.
1999: Brazelton T R; Adams B; Shorthouse R; Morris R E
Chronic rejection: the result of uncontrolled remodelling of graft tissue by recipient mesenchymal cells? Data from two rodent models and the effects of immunosuppressive therapies.
Inflammation research : official journal of the European Histamine Research Society ... [et al.] 1999;48 Suppl 2():S134-5.
1999: Slauson S; Billingham M E; Silva H T; Wang Y; Morris R E
Quilty effect in heterotopic cardiac allografts in malononitrilamide-treated rats.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1999;18(12):1251-3.
1999: Gummert J F; Barten M J; Sherwood S W; van Gelder T; Morris R E
Pharmacodynamics of immunosuppression by mycophenolic acid: inhibition of both lymphocyte proliferation and activation correlates with pharmacokinetics.
The Journal of pharmacology and experimental therapeutics 1999;291(3):1100-12.
1999: Jeremias A; Kolz M L; Ikonen T S; Gummert J F; Oshima A; Hayase M; Honda Y; Komiyama N; Berry G J; Morris R E; Yock P G; Fitzgerald P J
Feasibility of in vivo intravascular ultrasound tissue characterization in the detection of early vascular transplant rejection.
Circulation 1999;100(21):2127-30.
1999: Hausen B; Berry G J; Dagum P; Ikonen T; Christians U; Briffa N; Hook L; Morris R E
The histology of subcutaneously implanted donor bronchial rings correlates with rejection scores of lung allografts in a primate lung transplant model.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1999;18(7):714-24.
1999: Poston R S; Billingham M; Hoyt E G; Pollard J; Shorthouse R; Morris R E; Robbins R C
Rapamycin reverses chronic graft vascular disease in a novel cardiac allograft model.
Circulation 1999;100(1):67-74.
1999: Gummert J F; Ikonen T; Morris R E
Newer immunosuppressive drugs: a review.
Journal of the American Society of Nephrology : JASN 1999;10(6):1366-80.
1999: Gummert J F; Otto G; Barten M J; Morris R E
Effect of anesthesia on a whole blood lymphocyte proliferation assay in the rat.
Immunopharmacology and immunotoxicology 1999;21(2):267-76.
1999: Slauson S D; Silva H T; Sherwood S W; Morris R E
Flow cytometric analysis of the molecular mechanisms of immunosuppressive action of the active metabolite of leflunomide and its malononitrilamide analogues in a novel whole blood assay.
Immunology letters 1999;67(3):179-83.
1999: Hausen B; Boeke K; Berry G J; Segarra I; Benet L Z; Christians U; Morris R E
Coadministration of neoral and the novel rapamycin analog, SDZ RAD, to rat lung allograft recipients: potentiation of immunosuppressive efficacy and improvement of tolerability of staggered versus simultaneous treatment.
Transplantation 1999;67(7):956-62.
1999: Hausen B; Boeke K; Berry G J; Segarra I T; Christians U; Morris R E
Suppression of acute rejection in allogeneic rat lung transplantation: a study of the efficacy and pharmacokinetics of rapamycin derivative (SDZ RAD) used alone and in combination with a microemulsion formulation of cyclosporine.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1999;18(2):150-9.
1999: Ikonen T S; Gummert J F; Honda Y; Hayase M; Perlroth J; Hausen B; Barlow C; Fitzgerald P; Yock P G; Morris R E
Development of models of graft vascular disease in nonhuman primates: evaluation of GVD by intravascular ultrasound in a new cynomolgus model with arterial allograft exchange.
Transplantation proceedings 1999;31(1-2):687.
1999: Ikonen T S; Romanska H M; Bishop A E; Berry G J; Polak J M; Morris R E
Alterations in inducible nitric oxide synthase (iNOS) and nitrotyrosine (NitroY) during re-epithelialization of heterotopic rat tracheal composite grafts.
Transplantation proceedings 1999;31(1-2):182.
1999: Hausen B; Boeke K; Berry G J; Gummert J F; Christians U; Morris R E
Potentiation of immunosuppressive efficacy by combining the novel leflunomide analog, HMR 279, with microemulsion cyclosporine in a rat lung transplant model.
Transplantation 1999;67(3):354-9.
1999: Gummert J F; Christians U; Barten M; Silva H; Morris R E
High-performance liquid chromatographic assay with a simple extraction procedure for sensitive quantification of mycophenolic acid in rat and human plasma.
Journal of chromatography. B, Biomedical sciences and applications 1999;721(2):321-6.
1998: Segarra I; Brazelton T R; Guterman N; Hausen B; Jacobsen W; Morris R E; Benet L Z; Christians U
Development of a high-performance liquid chromatographic-electrospray mass spectrometric assay for the specific and sensitive quantification of the novel immunosuppressive macrolide 40-O-(2-hydroxyethyl)rapamycin.
Journal of chromatography. B, Biomedical sciences and applications 1998;720(1-2):179-87.
1998: Gregory C R; Stewart A; Sturges B; DeManvelle T; Cannon A; Ortega T; Harb M; Morris R E
Leflunomide effectively treats naturally occurring immune-mediated and inflammatory diseases of dogs that are unresponsive to conventional therapy.
Transplantation proceedings 1998;30(8):4143-8.
1998: Gummert J F; Ikonen T; Briffa N; Honda Y; Hayase M; Perlroth J; Kobayashi Y; Hausen B; Barlow C; Billingham M E; Fitzgerald P; Yock P G; Robbins R C; Morris R E
A new large-animal model for research of graft vascular disease.
Transplantation proceedings 1998;30(8):4023.
1998: Ikonen T; Uusitalo M; Taskinen E; Korpela A; Salminen U S; Morris R E; Harjula A L
Small airway obliteration in a new swine heterotopic lung and bronchial allograft model.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(10):945-53.
1998: Gregory C R; Galili U; Hancock W W; Valverde C R; Griffey S M; Berryman E R; Morris R E
Squirrel monkeys hyperacutely reject porcine musculocutaneous flaps despite a lack of naturally occurring xenoantibodies.
Transplantation proceedings 1998;30(4):1082-3.
1998: Gregory C R; Silva H T; Patz J D; Morris R E
Comparative effects of malononitriloamide analogs of leflunomide on whole blood lymphocyte stimulation in humans, rhesus macaques, cats, dogs, and rats.
Transplantation proceedings 1998;30(4):1047-8.
1998: Reichenspurner H; Soni V; Nitschke M; Berry G J; Brazelton T; Shorthouse R; Huang X; Boname J; Girgis R; Raitz B A; Mocarski E; Sandford G; Morris R E
Enhancement of obliterative airway disease in rat tracheal allografts infected with recombinant rat cytomegalovirus.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1998;17(5):439-51.
1998: Hausen B; Bahra M; Mueller P; Poets C F; Hewitt C W; Morris R E
Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 1998;11(3):186-94.
1997: Briffa N; Morris R E
New immunosuppressive regimens in lung transplantation.
The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 1997;10(11):2630-7.
1997: Salminen U S; Uusitalo M; Ikonen T; Taskinen E; Morris R E; Harjula A L
Effect of immunosuppression on obliterative lesions in a heterotopic large-animal bronchial allograft model.
Transplantation proceedings 1997;29(7):3155-6.
1997: Yeh L S; Gregory C R; Griffey S M; Lecouter R A; Hou S M; Morris R E
Combination leflunomide and cyclosporine prevents rejection of functional whole limb allografts in the rat.
Transplantation 1997;64(6):919-22.
1997: Hausen B; Mueller P; Bahra M; Ramsamooj R; Morris R E; Hewitt C W
Donor treatment with the lazeroid U74389G reduces ischemia-reperfusion injury in a rat lung transplant model.
The Annals of thoracic surgery 1997;64(3):814-20.
1997: Brazelton T R; Shorthouse R; Huang X; Morris R E
Infiltrating recipient mesenchymal cells form the obliterative airway disease lesion and dramatically remodel graft tissue in a model of chronic lung rejection.
Transplantation proceedings 1997;29(6):2614.
1997: Ikonen T; Uusitalo M; Taskinen E; Korpela A; Salminen U S; Morris R E; Harjula A L
A new large animal heterotopic lung and bronchial allograft model for research in obliterative bronchiolitis.
Transplantation proceedings 1997;29(6):2611-2.
1997: Reichenspurner H; Soni V; Nitschke M; Berry G J; Brazelton T R; Shorthouse R; Huang X; Reitz B A; Morris R E
Obliterative airway disease after heterotopic tracheal xenotransplantation: pathogenesis and prevention using new immunosuppressive agents.
Transplantation 1997;64(3):373-83.
1997: Hausen B; Morris R E
Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.
Clinics in chest medicine 1997;18(2):353-66.
1997: Silva H T; Cao W; Shorthouse R A; Löffler M; Morris R E
In vitro and in vivo effects of leflunomide, brequinar, and cyclosporine on pyrimidine biosynthesis.
Transplantation proceedings 1997;29(1-2):1292-3.
1997: Morikawa M; Shorthouse R A; Suto M J; Goldman M E; Morris R E
A novel inhibitor of nuclear factor-kappa B and activator protein-1 transcription factors in T cells suppresses host-versus-graft alloreactivity in vivo.
Transplantation proceedings 1997;29(1-2):1269-70.
1997: Nair R V; Huang X; Shorthouse R; Adams B; Brazelton T; Braun-Dullaeus R; Morris R E
Antiproliferative effect of rapamycin on growth factor-stimulated human adult lung fibroblasts in vitro may explain its superior efficacy for prevention and treatment of allograft obliterative airway disease in vivo.
Transplantation proceedings 1997;29(1-2):614-5.
1997: Fahrni J A; Berry G J; Morris R E; Rosen G D
Rapamycin inhibits development of obliterative airway disease in a murine heterotopic airway transplant model.
Transplantation 1997;63(4):533-7.
1996: Morris R E
Transplantation. Beware: shifting paradigms ahead.
Lancet 1996;348 Suppl 2():sII26.
1996: Silva H T; Shorthouse R; Morris R E
Single- and multiple-dose pharmacokinetics and pharmacodynamics of leflunomide's active metabolite A77 1726 in normal Lewis rats.
Transplantation proceedings 1996;28(6):3092-4.
1996: Silva H T; Cao W; Shorthouse R; Morris R E
Mechanism of action of leflunomide: in vivo uridine administration reverses its inhibition of lymphocyte proliferation.
Transplantation proceedings 1996;28(6):3082-4.
1996: Nair R V; Cao W; Morris R E
The antiproliferative effect of leflunomide on vascular smooth muscle cells in vitro is mediated by selective inhibition of pyrimidine biosynthesis.
Transplantation proceedings 1996;28(6):3081.
1996: Cao W W; Kao P N; Aoki Y; Xu J C; Shorthouse R A; Morris R E
A novel mechanism of action of the immunomodulatory drug, leflunomide: augmentation of the immunosuppressive cytokine, TGF-beta 1, and suppression of the immunostimulatory cytokine, IL-2.
Transplantation proceedings 1996;28(6):3079-80.
1996: Reichenspurner H; Girgis R E; Robbins R C; Yun K L; Nitschke M; Berry G J; Morris R E; Theodore J; Reitz B A
Stanford experience with obliterative bronchiolitis after lung and heart-lung transplantation.
The Annals of thoracic surgery 1996;62(5):1467-72; discussion 1472-3.
1996: Brazelton T R; Morris R E
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.
Current opinion in immunology 1996;8(5):710-20.
1996: Nakakura E K; Shorthouse R A; Zheng B; McCabe S M; Jardieu P M; Morris R E
Long-term survival of solid organ allografts by brief anti-lymphocyte function-associated antigen-1 monoclonal antibody monotherapy.
Transplantation 1996;62(5):547-52.
1996: Yeh L S; Gregory C R; Griffey S M; Lecouteur R A; Morris R E
Effects of leflunomide and cyclosporine on myocutaneous allograft survival in the rat.
Transplantation 1996;62(6):861-3.
1996: Lirtzman R A; Gregory C R; Levitski R E; Griffey S M; Yeh L S; Patz J D; Morris R E
Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model.
Transplantation proceedings 1996;28(2):945-7.
1996: Reichenspurner H; Adams B; Soni V; Brazelton T; Shorthouse R; Reitz B A; Berry G J; Morris R E
Obliterative airway disease after heterotopic tracheal xenotransplantation in a concordant rodent model: pathogenesis and treatment.
Transplantation proceedings 1996;28(2):729-30.
1995: Reichenspurner H; Girgis R E; Robbins R C; Conte J V; Nair R V; Valentine V; Berry G J; Morris R E; Theodore J; Reitz B A
Obliterative bronchiolitis after lung and heart-lung transplantation.
The Annals of thoracic surgery 1995;60(6):1845-53.
1995: Nair R V; Cao W; Morris R E
Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.
Immunology letters 1995;48(2):77-80.
1995: Morris R E
Mechanisms of action of new immunosuppressive drugs.
Therapeutic drug monitoring 1995;17(6):564-9.
1995: Yuh D D; Gandy K L; Morris R E; Hoyt G; Gutierrez J; Reitz B A; Robbins R C
Leflunomide prolongs pulmonary allograft and xenograft survival.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1995;14(6 Pt 1):1136-44.
1995: Cao W W; Kao P N; Chao A C; Gardner P; Ng J; Morris R E
Mechanism of the antiproliferative action of leflunomide. A77 1726, the active metabolite of leflunomide, does not block T-cell receptor-mediated signal transduction but its antiproliferative effects are antagonized by pyrimidine nucleosides.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1995;14(6 Pt 1):1016-30.
1995: Morris R E; Brown B W
Tacrolimus for prevention of liver allograft rejection: clinical trials and tribulations.
Lancet 1995;346(8986):1310-1.
1995: Nair R V; Cao W; Morris R E
Inhibition of smooth muscle cell proliferation in vitro by leflunomide, a new immunosuppressant, is antagonized by uridine.
Immunology letters 1995;47(3):171-4.
1995: Morris R E; Huang X; Gregory C R; Billingham M E; Rowan R; Shorthouse R; Berry G J
Studies in experimental models of chronic rejection: use of rapamycin (sirolimus) and isoxazole derivatives (leflunomide and its analogue) for the suppression of graft vascular disease and obliterative bronchiolitis.
Transplantation proceedings 1995;27(3):2068-9.
1995: Fealy M J; Most D; Huie P; Wolf M; Sibley R K; Morris R E; Press B H
Association of down-regulation of cytokine activity with rat hind limb allograft survival.
Transplantation 1995;59(10):1475-80.
1995: Gregory C R; Huang X; Pratt R E; Dzau V J; Shorthouse R; Billingham M E; Morris R E
Treatment with rapamycin and mycophenolic acid reduces arterial intimal thickening produced by mechanical injury and allows endothelial replacement.
Transplantation 1995;59(5):655-61.
1995: Morris R E; Huang X; Cao W; Zheng B; Shorthouse R A
Leflunomide (HWA 486) and its analog suppress T- and B-cell proliferation in vitro, acute rejection, ongoing rejection, and antidonor antibody synthesis in mouse, rat, and cynomolgus monkey transplant recipients as well as arterial intimal thickening after balloon catheter injury.
Transplantation proceedings 1995;27(1):445-7.
1995: Morris R E; Cao W; Huang X; Gregory C R; Billingham M E; Rowan R; Shorthouse R A
Rapamycin (Sirolimus) inhibits vascular smooth muscle DNA synthesis in vitro and suppresses narrowing in arterial allografts and in balloon-injured carotid arteries: evidence that rapamycin antagonizes growth factor action on immune and nonimmune cells.
Transplantation proceedings 1995;27(1):430-1.
1995: Cao W; Mohacsi P; Shorthouse R; Pratt R; Morris R E
Effects of rapamycin on growth factor-stimulated vascular smooth muscle cell DNA synthesis. Inhibition of basic fibroblast growth factor and platelet-derived growth factor action and antagonism of rapamycin by FK506.
Transplantation 1995;59(3):390-5.
1994: Mohacsi P J; Joshi A; Wang J; Morris R E; Billingham M E
Endocardial mononuclear cell infiltrates (Quilty effect) in heterotopic cardiac allografts in rapamycin-treated rats.
Transplantation proceedings 1994;26(6):3255-9.
1994: Fealy M J; Umansky W S; Bickel K D; Nino J J; Morris R E; Press B H
Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
Annals of surgery 1994;219(1):88-93.
1993: Morris R E
New small molecule immunosuppressants for transplantation: review of essential concepts.
The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 1993;12(6 Pt 2):S275-86.
1993: Gregory C R; Huie P; Billingham M E; Morris R E
Rapamycin inhibits arterial intimal thickening caused by both alloimmune and mechanical injury. Its effect on cellular, growth factor, and cytokine response in injured vessels.
Transplantation 1993;55(6):1409-18.
1993: Morris R E
Prevention and treatment of allograft rejection in vivo by rapamycin: molecular and cellular mechanisms of action.
Annals of the New York Academy of Sciences 1993;685():68-72.
1993: Murphy M P; Morris R E
Brequinar sodium effectively and potently suppresses allograft rejection in a heterotopic mouse heart transplant model.
Transplantation proceedings 1993;25(3 Suppl 2):75-6.
1993: Yuh D D; Morris R E
The immunopharmacology of immunosuppression by 15-deoxyspergualin.
Transplantation 1993;55(3):578-91.
1993: Morris R E
Commentary on new xenobiotic immunosuppressants for transplantation: Where are we, how did we get here, and where are we going?
Clinical transplantation 1993;7(1 part 2):138-46.
1993: Nakakura E K; McCabe S M; Zheng B; Shorthouse R A; Scheiner T M; Blank G; Jardieu P M; Morris R E
A non-lymphocyte-depleting monoclonal antibody to the adhesion molecule LFA-1 (CD11a) prevents sensitization to alloantigens and effectively prolongs the survival of heart allografts.
Transplantation proceedings 1993;25(1 Pt 1):809-12.
1993: Gregory C R; Huie P; Shorthouse R; Wang J; Rowan R; Billingham M E; Morris R E
Treatment with rapamycin blocks arterial intimal thickening following mechanical and alloimmune injury.
Transplantation proceedings 1993;25(1 Pt 1):120-1.
1993: Nakakura E K; McCabe S M; Zheng B; Shorthouse R A; Scheiner T M; Blank G; Jardieu P M; Morris R E
Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion.
Transplantation 1993;55(2):412-7.
1993: Gregory C R; Pratt R E; Huie P; Shorthouse R; Dzau V J; Billingham M E; Morris R E
Effects of treatment with cyclosporine, FK 506, rapamycin, mycophenolic acid, or deoxyspergualin on vascular muscle proliferation in vitro and in vivo.
Transplantation proceedings 1993;25(1 Pt 1):770-1.
1992: Mohacsi P J; Morris R E
Brief treatment with rapamycin in vivo increases responsiveness to alloantigens measured by the mixed lymphocyte response.
Immunology letters 1992;34(3):273-8.
1992: Morris R E
Immunopharmacology of new xenobiotic immunosuppressive molecules.
Seminars in nephrology 1992;12(4):304-14.
1991: Morris R E
In vivo immunopharmacology of the macrolides FK 506 and rapamycin: toward the era of rational immunosuppressive drug discovery, development, and use.
Transplantation proceedings 1991;23(6):2722-4.
1991: Meiser B M; Billingham M E; Morris R E
Effects of cyclosporin, FK506, and rapamycin on graft-vessel disease.
Lancet 1991;338(8778):1297-8.
1991: Morris R E
Rapamycin: FK506's fraternal twin or distant cousin?
Immunology today 1991;12(5):137-40.
1991: Morris R E; Wang J; Blum J R; Flavin T; Murphy M P; Almquist S J; Chu N; Tam Y L; Kaloostian M; Allison A C
Immunosuppressive effects of the morpholinoethyl ester of mycophenolic acid (RS-61443) in rat and nonhuman primate recipients of heart allografts.
Transplantation proceedings 1991;23(2 Suppl 2):19-25.
1991: Meiser B M; Morris R E
The importance of the spleen for the immunosuppressive action of cyclosporine in transplantation.
Transplantation 1991;51(3):690-6.
1991: Wang J; Morris R E
Effect of splenectomy and mono- or combination therapy with rapamycin, the morpholinoethyl ester of mycophenolic acid and deoxyspergualin on cardiac xenograft survival.
Transplantation proceedings 1991;23(1 Pt 1):699-702.
1991: Yuh D D; Morris R E
15-Deoxyspergualin is a more potent and effective immunosuppressant than cyclosporine but does not effectively suppress lymphoproliferation in vivo.
Transplantation proceedings 1991;23(1 Pt 1):535-9.
1991: Morris R E; Wang J
Comparison of the immunosuppressive effects of mycophenolic acid and the morpholinoethyl ester of mycophenolic acid (RS-61443) in recipients of heart allografts.
Transplantation proceedings 1991;23(1 Pt 1):493-6.
1991: Zheng B; Shorthouse R; Masek M A; Berry G; Billingham M E; Morris R E
Effects of the new and highly active immunosuppressant, rapamycin, on lymphoid tissues and cells in vivo.
Transplantation proceedings 1991;23(1 Pt 1):851-5.
1991: Flavin T; Ivens K; Wang J; Gutierrez J; Hoyt E G; Billingham M; Morris R E
Initial experience with FK 506 as an immunosuppressant for nonhuman primate recipients of cardiac allografts.
Transplantation proceedings 1991;23(1 Pt 1):531-2.
1991: Morris R E; Meiser B M; Wu J; Shorthouse R; Wang J
Use of rapamycin for the suppression of alloimmune reactions in vivo: schedule dependence, tolerance induction, synergy with cyclosporine and FK 506, and effect on host-versus-graft and graft-versus-host reactions.
Transplantation proceedings 1991;23(1 Pt 1):521-4.
1991: Wu J; Palladino M A; Figari I S; Morris R E
Comparative immunoregulatory effects of rapamycin, FK 506 and cyclosporine on mitogen-induced cytokine production and lymphoproliferation.
Transplantation proceedings 1991;23(1 Pt 1):238-40.
1990: Morris R E; Hoyt E G; Murphy M P; Eugui E M; Allison A C
Mycophenolic acid morpholinoethylester (RS-61443) is a new immunosuppressant that prevents and halts heart allograft rejection by selective inhibition of T- and B-cell purine synthesis.
Transplantation proceedings 1990;22(4):1659-62.
1990: Morris R E; Wu J; Shorthouse R
A study of the contrasting effects of cyclosporine, FK 506, and rapamycin on the suppression of allograft rejection.
Transplantation proceedings 1990;22(4):1638-41.
1990: Morris R E; Wu J; Shorthouse R
Comparative immunopharmacologic effects of FK 506 and CyA in in vivo models of organ transplantation.
Transplantation proceedings 1990;22(1):110-2.
1989: Babany G; Morris R E; Babany I; Shepherd S; Kates R E
In vivo evaluation of the effects of altered cyclosporine metabolism on its immunosuppressive potency.
The Journal of pharmacology and experimental therapeutics 1989;248(3):893-9.
1989: Yuh D D; Zurcher R P; Carmichael P G; Morris R E
Efficacy of didemnin B in suppressing allograft rejection in mice and rats.
Transplantation proceedings 1989;21(1 Pt 1):1141-3.
1989: Carmichael P G; Morris R E
Alteration of in vivo allogeneic functions by ultraviolet B.
Transplantation proceedings 1989;21(1 Pt 1):1137-8.
1989: Gudas V M; Carmichael P G; Morris R E
Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients.
Transplantation proceedings 1989;21(1 Pt 1):1072-3.
1989: Morris R E; Hoyt E G; Murphy M P; Shorthouse R
Immunopharmacology of FK-506.
Transplantation proceedings 1989;21(1 Pt 1):1042-4.
1988: Morris R E; Hoyt G; Baldwin J; Meiser B
Splenectomy antagonizes the action of cyclosporine.
Transplantation proceedings 1988;20(3 Suppl 3):1079-80.
1988: Babany G; Morris R E; Babany I; Kates R E
Evaluation of the in vivo dose-response relationship of immunosuppressive drugs using a mouse heart transplant model: application to cyclosporine.
The Journal of pharmacology and experimental therapeutics 1988;244(1):259-62.
1987: Morris R E; Hoyt G; DeValeria P
A comparison of the in vitro and in vivo immunologic activities of concanavalin A and its succinylated derivative.
Transplantation proceedings 1987;19(1 Pt 1):626-7.
1987: Cheng P J; Morris R E
A new, rapid, high-capacity chromatographic purification of IgG 1 monoclonal antibodies directly from mouse ascites fluid.
Transplantation proceedings 1987;19(1 Pt 1):607-9.
1987: Anderson J E; Morris R E; Blaschke T F
Ketoconazole potentiates cyclosporine immunosuppression and toxicity in mice.
Transplantation proceedings 1987;19(1 Pt 2):1267-8.
1987: Morris R E; DeValeria P; Skogen B; Pratt F P; Cheng P J; Kim J; Clark W A
Intravenously injected anti-cardiac myosin monoclonal antibody specifically demarcates cardiac rejection.
Transplantation proceedings 1987;19(1 Pt 2):1053-5.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

randall morris

Research Profile (preview)

Chemicals & Drugs

Physiology

Living Beings

Procedures

Disorders

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of randall morris (preview)

All Publications